Platinum International Health Sciences P - Managed Fund

Fund Objective

The Fund primarily invests in health care companies listed on securities markets around the world. It invests in companies engaged in many aspects of providing products and services to the health care industry such as biotechnology, pharmaceuticals, diagnostics, laboratory technologies, distribution, hospitals and nursing care, health insurance and the provision of information technology to such companies.

Fund Strategy

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}

Peers

Benchmark ({{ fund.benchmark.name }})

{{ fund.model.name }}

The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.

Fees Comparison

% p.a.

Average of peers ({{ fund.benchmark.peers.peerCount }})

NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.

Fund performance

	1M	3M	6M	1Y p.a.	2Y p.a.	3Y p.a.	5Y p.a.	10Y p.a.
Total return	-3.81%	-3.03%	6.67%	43.85%	12.75%	11.87%	2.76%	-%
Growth return	-3.69%	-2.67%	7.19%	44.55%	13.02%	11.81%	-0.24%	-%
Income return	-0.12%	-0.36%	-0.52%	-0.7%	-0.27%	0.06%	3%	-%

As at 30 Apr 2026. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

Platinum International Health Sciences P

Australian Equities: 15.87%

International Equities: 79.39%

Cash: 4.74%

General Information

Fund Details

Type	Description
Fund Name	Platinum International Health Sciences P
Responsible Entity	Platinum Asset Management
APIR Code	PLA6965AU
Morningstar Rating	Not Rated
Legal Structure	Unknown
Fund Inception	3 Jul 2017
Fund Size	$204.3 million (as at 31 Jan 2026)
Entry Price	$1.3916 (as at 6 May 2026)
Exit Price	$1.3874 (as at 6 May 2026)
Fund Status	Open

Offer information

Type	Description
MER	1.46% (as at 31 Mar 2026)
Indirect Cost Ratio (ICR)	1.10% (as at 30 Jun 2025)
Minimum initial investment	$10,000.00
Minimum additional investments
Minimum redemption amount	$10,000.00

Top 10 holdings (as at 31 Mar 2026)

Holding (as at 31 Mar 2026)	Type	% of Portfolio
Imricor Medical Systems Inc Chess Depository Interest		5.67%
Login now to view the complete list of holdings.

Your guide to next steps

Dealing with a struggling fund? What to Do and Look For

Your managed fund switching checklist. Is fear of capital gains tax holding you back?

The Great Investment Fee Scam is hiding in plain sight. And it's ripping us all off.

Guide to tidying up your Portfolio Manager holdings

FAQs about the Platinum International Health Sciences P

What is the objective of the Platinum International Health Sciences P managed fund?

The objective of the Platinum International Health Sciences P managed fund is The Fund primarily invests in health care companies listed on securities markets around the world. It invests in companies engaged in many aspects of providing products and services to the health care industry such as biotechnology, pharmaceuticals, diagnostics, laboratory technologies, distribution, hospitals and nursing care, health insurance and the provision of information technology to such companies.

What is the strategy for the Platinum International Health Sciences P managed fund?

The strategy of the Platinum International Health Sciences P managed fund is The Fund primarily invests in health care companies listed on securities markets around the world. It invests in companies engaged in many aspects of providing products and services to the health care industry such as biotechnology, pharmaceuticals, diagnostics, laboratory technologies, distribution, hospitals and nursing care, health insurance and the provision of information technology to such companies.

What is the APIR code of the Platinum International Health Sciences P managed fund?

The APIR code of the Platinum International Health Sciences P managed fund is PLA6965AU.

What was Platinum International Health Sciences P’s total return last month?

Platinum International Health Sciences P’s total return last month was -3.81%. This was made up of a growth return of -3.69% and an income return of -0.12%. These returns were calculated as at 30 Apr 2026.

What was Platinum International Health Sciences P’s total return for the last three months?

Platinum International Health Sciences P’s total return for the last three months was -3.03%. This was made up of a growth return of -2.67% and an income return of -0.36%%. These returns were calculated as at 30 Apr 2026.

What is Platinum International Health Sciences P’s one-year total return?

Platinum International Health Sciences P’s one-year total return is 43.85%. This was made up of a growth return of 44.55% and an income return of -0.7%. These returns were calculated as at 30 Apr 2026.

What is Platinum International Health Sciences P’s three-year total return?

Platinum International Health Sciences P’s one-year total return is 11.87%. This was made up of a growth return of 11.81% and an income return of 0.06%. These returns were calculated as at 30 Apr 2026.

What is the asset allocation of the Platinum International Health Sciences P managed fund?

The asset allocation of the Platinum International Health Sciences P managed fund is :

Australian Equities: 15.87%

International Equities: 79.39%

Cash: 4.74%

Who is the responsible Entity of the Platinum International Health Sciences P managed fund?

The Responsible Entity for the Platinum International Health Sciences P managed fund is Platinum Asset Management.

What is the size of the Platinum International Health Sciences P managed fund?

As at 31 Jan 2026, the size of the Platinum International Health Sciences P managed fund was $204.3 million.

What is the inception date of the Platinum International Health Sciences P managed fund?

The Platinum International Health Sciences P managed fund has an inception date of 3 Jul 2017.

What is the current entry price of the Platinum International Health Sciences P managed fund?

The current entry price of the Platinum International Health Sciences P managed fund is $1.3916 per unit and the current exit price is $1.3874 per unit (as at 6 May 2026).

What is the current exit price of the Platinum International Health Sciences P managed fund?

The current exit price of the Platinum International Health Sciences P managed fund is $1.3874 per unit and the current entry price is $1.3916 per unit (as at 6 May 2026).

What is the minimum investment amount for the Platinum International Health Sciences P managed fund?

The minimum initial investment amount for the Platinum International Health Sciences P managed fund is $10,000. Minimum additional investment is $0.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.

What our members say about us